Literature DB >> 4541683

Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children.

F L Ruben, E A Smith, S O Foster, H L Casey, J M Pifer, R B Wallace, A I Atta, W L Jones, R B Arnold, B E Teller, Z Q Shaikh, B Lourie, D L Eddins, S M Doko, W H Foege.   

Abstract

Children receiving smallpox, measles, and yellow fever vaccines simultaneously at separate sites responded adequately to all three vaccines. In those children, 9 months of age and older, who received these three vaccines in addition to diphtheria-pertussis-tetanus vaccine, there was a decrease in measles seroconversion rates from 89% to 70%. Possible interactions between live and killed vaccines should be considered when the administration of multiple antigens is planned.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4541683      PMCID： PMC2481001     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  16 in total

1.  Combined immunization against poliomyelitis, diphtheria, whooping cough, tetanus and smallpox.

Authors:  P A WINTER; J H MASON; E KUHR; A W SCHAAFSMA; M ROBINSON; L R SAAYMAN; R G SPENCE
Journal:  S Afr Med J       Date:  1963-05-11

2.  Diphtheria antitoxin levels in the serum of Gambian Africans.

Authors:  M BARR; I A McGREGOR
Journal:  Trans R Soc Trop Med Hyg       Date:  1962-09       Impact factor: 2.184

3.  Vaccination by scarification with a combined 17D yellow fever and vaccinia vaccine.

Authors:  G W A DICK; E S HORGAN
Journal:  J Hyg (Lond)       Date:  1952-09

4.  Yellow Fever Vaccination, Simple or Associated with Vaccination Against Smallpox, of the Populations of French West Africa by the Method of the Pasteur Institute of Dakar.

Authors:  M G Peltier
Journal:  Am J Public Health Nations Health       Date:  1947-08

5.  Safety and effectiveness of multiple antigen preparations in a group of free-living children.

Authors:  V K VOLK
Journal:  Am J Public Health Nations Health       Date:  1949-10

6.  Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.

Authors:  R E Weibel; J Stokes; E B Buynak; M B Leagus; M R Hilleman
Journal:  Pediatrics       Date:  1969-04       Impact factor: 7.124

7.  Studies on California encephalitis in Minnesota.

Authors:  T P Monath; J G Nuckolls; H Bauer; W A Chappell; P H Coleman
Journal:  Am J Epidemiol       Date:  1970-07       Impact factor: 4.897

8.  Agglutinin response to pertussis vaccine. I. Effect of dosage and interval.

Authors:  J Wilkins; F F Williams; P F Wehrle; B Portnoy
Journal:  J Pediatr       Date:  1971-08       Impact factor: 4.406

9.  Simultaneous administration of live measles virus vaccine and smallpox vaccine.

Authors:  P M Sherman; R G Hendrickse; D Montefiore; T Peradze; G Coker
Journal:  Br Med J       Date:  1967-06-10

10.  RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.

Authors:  H M MEYER; D D HOSTETLER; B C BERNHEIN; N G ROGERS; P LAMBIN; A CHASSARY; R LABUSQUIERE; J E SMADEL
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408
View more
  10 in total

1.  A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray.

Authors:  Peter D Crompton; Matthew A Kayala; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Greta E Weiss; Douglas M Molina; Chad R Burk; Michael Waisberg; Algis Jasinskas; Xiaolin Tan; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; David L Narum; Xiaowu Liang; Ogobara K Doumbo; Louis H Miller; Denise L Doolan; Pierre Baldi; Philip L Felgner; Susan K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

2.  Pertussis in a rural area of Kenya: epidemiology and a preliminary report on a vaccine trial.

Authors:  J M Mahieu; A S Muller; A M Voorhoeve; H Dikken
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

3.  Body height and immune efficacy: testing body stature as a signal of biological quality.

Authors:  Bogusław Pawłowski; Judyta Nowak; Barbara Borkowska; Daria Augustyniak; Zuzanna Drulis-Kawa
Journal:  Proc Biol Sci       Date:  2017-07-26       Impact factor: 5.349

4.  The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections.

Authors:  Greta E Weiss; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; Seydou Dia; Agnes Guindo; Abdramane Traore; Chiung-Yu Huang; Kazutoyo Miura; Marko Mircetic; Shanping Li; Amy Baughman; David L Narum; Louis H Miller; Ogobara K Doumbo; Susan K Pierce; Peter D Crompton
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

5.  Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen.

Authors:  P Coursaget; B Yvonnet; E H Relyveld; J L Barres; I Diop-Mar; J P Chiron
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

6.  Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis.

Authors:  Laurie L Kenney; Markus Cornberg; Alex T Chen; Sebastien Emonet; Juan Carlos de la Torre; Liisa K Selin
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

7.  Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine.

Authors:  G Giammanco; S Li Volti; I Salemi; G Giammanco Bilancia; L Mauro
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

Review 8.  The role of research in viral disease eradication and elimination programs: lessons for malaria eradication.

Authors:  Joel G Breman; Ciro A de Quadros; Walter R Dowdle; William H Foege; Donald A Henderson; T Jacob John; Myron M Levine
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

9.  A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old.

Authors: 
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-09       Impact factor: 2.743

10.  Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Authors:  Sara Carazo; Marie-Noëlle Billard; Amélie Boutin; Gaston De Serres
Journal:  BMC Infect Dis       Date:  2020-03-29       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.